Increasing Physical Activity Through Social Support and Stress Resilience
I-PASS
2 other identifiers
interventional
86
1 country
1
Brief Summary
The goal of this clinical trial is to learn the effects of technology enhancements when combined with basic education, goal-setting, and self-monitoring to increase physical activity among older adults living alone, experiencing subjective cognitive decline, and currently engaging minimal physical activity (60 minutes or less of moderate to vigorous physical activity). Further, we will examine key psychosocial mechanisms believed to contribute to successful promotion of physical activity, which include social support and stress resilience. The primary questions are to determine whether
- the tech-enhanced condition lead to greater physical activity over time?
- the tech-enhanced condition lead to social support and stress resilience over time?
- social support and stress resilience mediate the relationship between the study condition and physical activity? All participants will engage in self-monitoring of physical activity, will receive weekly text reminders of their physical activity goals for the week, and will receive basic education about the importance of physical activity, social support, and stress resilience for cognitive, physical, and psychological health. Participants in the tech-enhanced condition will also receive access to a study-specific website and virtual coaching to reinforce the information presented. Researchers will then compare the tech-enhanced condition to the basic education condition to determine the benefits of technology to deliver the intervention materials in order to increase physical activity, social support, and stress resilience. Participants will:
- Use a Garmin wearable device to monitor their physical activity
- Be randomly assigned to a basic education condition or tech-enhanced condition
- Set achievable goals for weekly physical activity, with incremental increases to achieve 7000 average daily steps by the end of the study
- Respond to surveys to monitor their social support, stress resilience, quality of life, and depression. The sample has several risk factors for Alzheimer's disease and related dementias: low physical activity, social isolation risk via living alone, and subjective cognitive impairment. Therefore, a long-term goal includes the determination of the intervention's effectiveness at increasing physical activity, social support, and stress resilience to reduce risk for developing dementia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy
Started Jun 2025
Typical duration for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 20, 2025
CompletedFirst Posted
Study publicly available on registry
March 26, 2025
CompletedStudy Start
First participant enrolled
June 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
May 7, 2026
April 1, 2026
1.4 years
March 20, 2025
May 5, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Change in accelerometer-measured moderate to vigorous physical activity
ActiGraph GT9X Link Activity monitors worn on non-dominant wrist during waking hours 7 consecutive days will provide objective measure of 1) average daily steps and 2) moderate to vigorous activity prior to and after the intervention. GTX9X data (collected in raw format) will be aggregated for analysis to epochs of 60 secs or less for comparability to other studies.
One week at baseline and one week after intervention concludes
Change in self-reported physical activity
Participants will complete an abbreviated 7-Day Physical Activity Recall interview, which assesses self-reported moderate to vigorous physical activity.
Reported at baseline and after the 3 month intervention
Secondary Outcomes (13)
Objective Stress Resilience
Assessed at baseline and after the 3 month intervention
Self-reported stress
Assessed at baseline, end of month 1, end of month 2, and end of month 3
Brief Resilience Scale
Assessed at baseline, end of month 1, end of month 2, and end of month 3
Social Isolation
Assessed at baseline, end of month 1, end of month 2, and end of month 3
Self-reported loneliness
Assessed at baseline, end of month 1, end of month 2, and end of month 3
- +8 more secondary outcomes
Other Outcomes (11)
Cognitive Health
Assessed during online eligibility screening and after the 3 month intervention
Functional Activities
Assessed at baseline and after the 3 month intervention
Change in Garmin-assessed physical activity
From enrollment to the end of treatment at 3 months
- +8 more other outcomes
Study Arms (2)
Tech-enhanced condition
EXPERIMENTALParticipants in the tech-enhanced condition will receive access to a study specific website (to be developed into an app) and guided use via individual coaching sessions delivered on Zoom. Coaching sessions will align with and reinforce website content, which includes information about the importance of and strategies to increase physical activity, social support, and stress resilience.
Control condition
ACTIVE COMPARATORParticipants in the control condition will receive a study-specific manual containing basic education about the importance of and strategies to increase physical activity, social support, and stress resilience.
Interventions
All participants will receive a Garmin and use the associated app to monitor their weekly physical activity. Enrolled participants are insufficiently active (engaging in 60 minutes or less of moderate to vigorous physical activity per week) and will receive weekly text messages to incrementally increase physical activity over the course of the study. Goals will be 20% greater than the average daily steps from the previous week, with the ultimate goal of reaching 7000 average daily steps. 7000 average daily steps was selected based on recent findings that it is associated with clinically meaningful health outcomes and being an achievable target for most adults.
Eligibility Criteria
You may qualify if:
- Aged 60 years or older
- Living alone and community dwelling
- Engaging in 60 minutes or less per week of self-reported moderate-to-vigorous physical activity at screening (based on Exercise Vital Sign Questionnaire)
- Self-reported decline in cognitive functioning
- Self-reported ownership of/willingness to use a smartphone with an iOS or Android operating system (necessary for participants to track their activity using a wearable activity monitor).
- Able to read and speak in English. We hope to offer the intervention in Spanish in the future; however, currently, the study materials are only available in English, and participation will require ability to read and respond to study materials.
You may not qualify if:
- Endorsing an item on the Physical Activity Readiness Questionnaire (PAR-Q), unless a physician's note is provided
- Resting blood pressure greater than 200/110 mmHG as assessed at the baseline study assessment (unless a physician's note is provided)
- Plans to relocate out of metropolitan Phoenix, Arizona area in the next 6 months
- Participation in another physical activity, nutrition or weight loss program at time of screening or at any time during the intervention
- Individuals with neurodegenerative (e.g., dementia), developmental (e.g., autism), neurologic (e.g., Parkinson's, epilepsy), or major psychiatric (e.g., bipolar, schizophrenia) diagnoses
- Being previously prescribed one of the 5 approved Alzheimer's medications, including: Donepezil (Aricept), Rivastigmine (Exelon), Galantamine (Razadyne), Memantine (Namenda), Memantine + Donepezil (Namzaric)
- Score of 9 or higher on the 15-item Geriatric Depression Scale (GDS) at the Baseline Session \[scores of 9 and higher are indicative of moderate to severe depression\]
- History of stroke
- Incarcerated individuals (i.e., Prisoners)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Arizona State Universitylead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
Arizona State University
Phoenix, Arizona, 85004, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Molly Maxfield
Arizona State University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 20, 2025
First Posted
March 26, 2025
Study Start
June 23, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
January 1, 2027
Last Updated
May 7, 2026
Record last verified: 2026-04